Latest News and Press Releases

SARASOTA, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug...

SARASOTA, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug...

PharmAla releases Q2 financial statements showing increased customer deposits, shipments

Nearly 60 Ukrainian therapists will attend the event at no cost, learning fundamentals and best practices for psychedelic-assisted therapiesMore than 300 practitioners from more than 30 countries have...

Washington, DC, and Smithtown, NY, April 02, 2025 (GLOBE NEWSWIRE) -- America's VetDogs, a leading national nonprofit provider of service dogs to veterans, active-duty service members, and first...

New York, April 02, 2025 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) invites the public to a free webinar, “Developing a Potential New Treatment for Chronic PTSD:...

PRESTON, Wash., March 24, 2025 (GLOBE NEWSWIRE) -- Today Sparkling Ice®, crafted by Talking Rain Beverage Company®, reconfirmed its commitment to “saving lives at both ends of the leash” with the...

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial for AL001 Treatment of Post-Traumatic Stress Disorder at Massachusetts General Hospital

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder at Massachusetts General Hospital

PharmAla to supply the STRONG STAR Consortium with new 20mg MDMA dose to treat active-duty military personnel in a clinical trial